Peking University Cancer Hospital北京大学肿瘤医院
Official English-profile portrait for Ji Jiafu on the Peking University Cancer Hospital site.
Gastrointestinal Cancer Center

Ji Jiafu

季加孚

Academic HonourProfessor of Surgery
LeadershipDirector, Department of Surgery
CredentialsChief Expert, Gastrointestinal Cancer Center
Peking University Cancer Hospital北京大学肿瘤医院· Beijing

Areas of Expertise

Gastric cancer surgeryD2 lymphadenectomyPerioperative integrated treatment for gastric cancerLaparoscopic gastrectomyTranslational gastrointestinal oncology
Request Consultation with Jiafu

Professional Biography

Dr. Ji Jiafu is Professor of Surgery at Peking University Cancer Hospital, Beijing. Jiafu specializes in Gastric cancer surgery, D2 lymphadenectomy, perioperative integrated treatment for gastric cancer, laparoscopic gastrectomy, and translational gastrointestinal oncology.

Education & Training

  • Inner Mongolia Medical College (1982)
  • Master of Medicine in Oncology; PhD in Oncology; DrPH, Beijing Medical University; Cardiff University; Johns Hopkins University
  • Stanford University — Postdoctoral research in oncology (United States)

Notable Publications

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

The Lancet (2012) — co-author

PubMed/DOI

Assessment of Laparoscopic Distal Gastrectomy After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Randomized Clinical Trial.

JAMA Surgery (2019) — co-author

PubMed/DOI

Leadership & Positions

  • Chief Expert, Gastrointestinal Cancer Center, Peking University Cancer Hospital
  • Director, Department of Surgery, Peking University Cancer Hospital
  • Former President, Peking University Cancer Hospital

Pioneering Contributions

1

Pioneered a modularized D2 gastrectomy approach that breaks the operation into 12 standardized modules, helping reduce national D2 gastrectomy mortality in China to 0.24%.

2

Helped establish perioperative integrated treatment pathways for locally advanced gastric cancer, including CapOX-based adjuvant and perioperative strategies incorporated into practice-changing studies.

3

Built and led a comprehensive gastric cancer prevention and treatment system integrating surgery, systemic therapy, AI-assisted diagnosis, and translational biobanking research.

International Patient Services

Full support for your journey to China

Medipath provides comprehensive support for international patients. Services include full English-speaking medical consultations, dedicated medical translation staff, and specialized assistance with medical visa applications to ensure a seamless healthcare journey.

English Consultations

Full English-speaking medical appointments

Medical Translation

Dedicated translation for all documentation

Visa Assistance

Medical visa application support